Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 23979232)

1.

[Life style-related disorders and independence in old patients - dyslipidemia].

Eto M.

Nihon Ronen Igakkai Zasshi. 2013;50(2):176-7. Japanese. No abstract available.

2.
3.

Using cardiovascular age equivalent to close the treatment gap for dyslipidemia.

Eaton CB.

Arch Intern Med. 2007 Nov 26;167(21):2288. No abstract available.

PMID:
18039985
4.

Screening and treatment of dyslipidemias in children and adolescents.

Daniels SR.

Horm Res Paediatr. 2011;76 Suppl 1:47-51. doi: 10.1159/000329163. Epub 2011 Jul 21. Review.

PMID:
21778749
5.

Atherogenic dyslipidemia.

Hayden MR.

J Cardiometab Syndr. 2006 Summer;1(3):166-7. No abstract available.

PMID:
17679821
6.

Dyslipidemia in menopause: mechanisms and management.

Schnatz PF, Schnatz JD.

Obstet Gynecol Surv. 2006 Sep;61(9):608-13. Review.

PMID:
16919179
7.

[Dyslipidemia as a therapeutic target for prevention of cardiovascular events and end-stage renal disease].

Watanabe T.

Nihon Rinsho. 2008 Sep;66(9):1761-9. Review. Japanese.

PMID:
18788407
8.

Lifestyle affects risk of two brain disorders.

[No authors listed]

Health News. 2002 Nov;8(11):7. No abstract available.

PMID:
12523252
9.

Atherosclerosis prevention and treatment in children and adolescents.

Oliveira FL, Patin RV, Escriv√£o MA.

Expert Rev Cardiovasc Ther. 2010 Apr;8(4):513-28. doi: 10.1586/erc.09.170. Review.

PMID:
20397826
10.

[Bone diseases caused by impaired glucose and lipid metabolism].

Kanazawa I, Sugimoto T.

Clin Calcium. 2013 Nov;23(11):1605-11. doi: CliCa131116051611. Review. Japanese.

PMID:
24162600
11.

[Treatment of vascular risk factors].

Hanyu H.

Nihon Ronen Igakkai Zasshi. 2012;49(3):284-7. Japanese. No abstract available.

12.

Dyslipidemia and the risk of Alzheimer's disease.

Reitz C.

Curr Atheroscler Rep. 2013 Mar;15(3):307. doi: 10.1007/s11883-012-0307-3. Review.

13.

[Interventions for life style related disease in the elderly: dyslipidemia].

Katsuya T.

Nihon Ronen Igakkai Zasshi. 2011;48(1):29-32. Japanese. No abstract available.

14.

Prediction is difficult, particularly about the future.

Jackson R, Wells S.

Arch Intern Med. 2007 Nov 26;167(21):2286-7. No abstract available.

PMID:
18039984
15.

Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.

Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, Boudreau G; Cardiovascular Health Evaluation to Improve Compliance and Knowledge Among Uninformed Patients (CHECK-UP) Study Group.

Arch Intern Med. 2007 Nov 26;167(21):2296-303.

PMID:
18039987
16.

The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression.

van Reedt Dortland AK, Vreeburg SA, Giltay EJ, Licht CM, Vogelzangs N, van Veen T, de Geus EJ, Penninx BW, Zitman FG.

Psychoneuroendocrinology. 2013 Feb;38(2):209-18. doi: 10.1016/j.psyneuen.2012.05.017. Epub 2012 Jun 18.

PMID:
22717171
17.

[Chlamydia pneumoniae infection increases the risk of coronary artery disease in the patients with dyslipidemia].

Sun YH, Pei WD, Wu YJ, Ye SD, Wang GG, Gao RL, Yang YJ.

Zhonghua Yi Xue Za Zhi. 2004 Dec 2;84(23):1990-3. Chinese.

PMID:
15730813
18.

[Dementia and lifestyle-related diseases in Japanese aging society].

Iwamoto T.

Nihon Rinsho. 2011 May;69(5):953-63. Japanese.

PMID:
21595287
19.

Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.

Liu CS, Hsu HS, Li CI, Jan CI, Li TC, Lin WY, Lin T, Chen YC, Lee CC, Lin CC.

BMC Gastroenterol. 2010 May 27;10:51. doi: 10.1186/1471-230X-10-51.

20.

Accounting for individual differences in risk of Alzheimer disease.

Grant W.

PLoS Med. 2005 Mar;2(3):e82; author reply e86. Epub 2005 Mar 29. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk